BCS and IVIVC Based Biowaivers
The term bioweber applies to the regulatory approval process when a document (application) is approved based on evidence of equivalence other than in vivo bioequivalence testing. For solid oral dosage forms, Bioweber is generally based on dissolution tests. • BCS is a scientific framework for classifying drug substances based on water solubility and intestinal permeability. In combination with drug lysis, BCS takes into account three major factors that determine the rate and extent of absorption of solid oral IR dosage forms: lysis, solubility, and intestinal permeability.
Related Conference of BCS and IVIVC Based Biowaivers
July 25-26, 2024
4th International Conference on Biomedicine & Pharmacotherapy
Prague, Czech Republic
BCS and IVIVC Based Biowaivers Conference Speakers
Recommended Sessions
- Advanced Drug Delivery System
- BCS and IVIVC Based Biowaivers
- Biological Medicine
- Biopharmaceutical Informatics
- Chemical and Analytical Strategies for Biosimilars
- Consequences of Brexit on Biosimilars
- Digital Pharma
- Drug Delivery Technology
- Drug Formulation
- Encapsulated Drugs
- Intellectual Property Rights
- Pharmaceutical Chemistry
- Pharmaceutical Manufacturing
- Pharmacogenomics